Headquarters
3160 PORTER DRIVE SUITE 250, PALO ALTO, CA 94304, US
PALO ALTO, CA, US
BRIDGEBIO PHARMA, INC.
From the company
BridgeBio Pharma, Inc. is a biotechnology company focused on developing medicines for genetic conditions. It operates a decentralized hub-and-spoke model called The Bridge Way, in which autonomous affiliate teams focus on specific conditions or drug candidates while a central hub provides clinical, regulatory, and commercial capabilities. Its pipeline includes approved products Attruby (acoramidis) and NULIBRY (fosdenopterin), plus investigational candidates such as encaleret, BBP-418, and infigratinib.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.